Cargando…
Activation of the integrated stress response is a vulnerability for multidrug‐resistant FBXW7‐deficient cells
FBXW7 is one of the most frequently mutated tumor suppressors, deficiency of which has been associated with resistance to some anticancer therapies. Through bioinformatics and genome‐wide CRISPR screens, we here reveal that FBXW7 deficiency leads to multidrug resistance (MDR). Proteomic analyses fou...
Autores principales: | Sanchez‐Burgos, Laura, Navarro‐González, Belén, García‐Martín, Santiago, Sirozh, Oleksandra, Mota‐Pino, Jorge, Fueyo‐Marcos, Elena, Tejero, Héctor, Antón, Marta Elena, Murga, Matilde, Al‐Shahrour, Fátima, Fernandez‐Capetillo, Oscar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449593/ https://www.ncbi.nlm.nih.gov/pubmed/35861150 http://dx.doi.org/10.15252/emmm.202215855 |
Ejemplares similares
-
PD-L1(ATTAC) mice reveal the potential of depleting PD-L1 expressing cells in cancer therapy
por: Fueyo-Marcos, Elena, et al.
Publicado: (2023) -
Emerging concepts in drug discovery for cancer therapy
por: Murga, Matilde, et al.
Publicado: (2022) -
An in silico analysis identifies drugs potentially modulating the cytokine storm triggered by SARS-CoV-2 infection
por: Sanchez-Burgos, Laura, et al.
Publicado: (2022) -
vulcanSpot: a tool to prioritize therapeutic vulnerabilities in cancer
por: Perales-Patón, Javier, et al.
Publicado: (2019) -
New regulators of the tetracycline‐inducible gene expression system identified by chemical and genetic screens
por: Colicchia, Valeria, et al.
Publicado: (2022)